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Rat liver fructose-1,6-bisphosphatase was partially phosphorylated in vitro and separated into 
unphosphorylated and fully phosphorylated enzyme. The effects of fructose 2,dbisphosphate and AMP 
on these two enzyme forms were examined. Unphosphorylated fructose-l ,dbisphosphatase was more 
easily inhibited by both effecters. Fructose 2,dbisphosphate affected both Ko.5 and V,,, while the main 
effect of AMP was to lower V,,. Fructose 2,dbisphosphate and AMP together acted synergistically to 
decrease the activity of fructose-1,6-bisphosphatase, and since unphosphorylated and phosphorylated 
enzyme forms are affected differently, this might be a way to amplify the effect of phosphorylation. 
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1. INTRODUCTION 
The newly discovered sugar diphosphate, fruc- 
tose 2,dbisphosphate (F2,6Pz), has become of in- 
creasing interest during the last few years. Its effect 
on 6-phosphofructo-1-kinase has been thoroughly 
investigated, and it has been reported that phos- 
phorylation of this enzyme decreases its affinity 
for the effector [l]. The most striking influence of 
F2,6Pz on this enzyme is to decrease the inhibitory 
effect of ATP [l]. 
The bifunctional enzyme responsible for the syn- 
thesis and degradation of F2,6Pz has been purified 
[2], and the action of various effecters on its activi- 
ty has been investigated [3,4]. In addition, studies 
of the hormonal regulation of the enzyme show 
that the level of F2,6Pz can be lowered by both 
glucagon and epinephrine [5,6]. 
F1,6Pzase) is inhibited by F2,6P2. This has been 
shown for F1,6Pzase in organs from various mam- 
mals such as rabbit liver [7], rabbit muscle [8], 
swine kidney [9,10], rat liver [8,11,12] and bovine 
liver [13]. The nature of this inhibition has at- 
tracted much interest, especially when it was found 
to be synergistic with the effect of AMP [7-l 11, a 
well known allosteric inhibitor of F1,6Pzase. 
F2,6P2 is currently believed to be a purely com- 
petitive inhibitor, but a recent suggestion is that it 
also interacts with a site other than the catalytic 
one [13]. 
It has been reported by several authors that 
fructose-l ,dbisphosphatase (D-fructose-l ,6-bis- 
phosphate 1-phosphohydrolase, EC 3.1.3.11; 
Rat liver F1,6Pzase is known to be phos- 
phorylated in vitro by CAMP-dependent protein 
kinase, leading to a decreased KO.S for F1,6Pz [ 141. 
Reports in the literature concerned with the pro- 
cess in vivo have been inconclusive on this point: 
authors in [14] reported an increase in activity of 
the enzyme whereas those in [15] found no change 
in the activity of phosphorylated F1,6Pzase. 
Here we have separated phosphorylated and un- 
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phosphorylated F1,6Pzase. This has not been done 
previously, perhaps due to the difficulty en- 
countered in obtaining completely phosphorylated 
enzyme, particularly as the phosphate-receptor se- 
quence is prone to proteolytic cleavage [la, 171. 
When the activities of unphosphorylated and 
phosphorylated F1,6Pzase were compared in the 
presence of F2,6Pz and/or AMP it was observed 
that the unphosphorylated form of F1,6Pzase was 
more sensitive to inhibition by both effecters. 
2. MATERIALS AND METHODS 
2.1. Materials 
Bovine serum albumin, AMP cyclic AMP, di- 
thiothreitol (DTT), NADP, Fl,6Pz, F2,6P2 and 
Coomassie brilliant blue G-250 were from Sigma. 
[32P]ATP was bought from New England Nuclear. 
Sephadex G-50, Polybuffer Exchanger PBE 94 and 
Polybuffer 74 were purchased from Pharmacia, 
Uppsala. Glucose-6-phosphate dehydrogenase and 
phosphohexose isomerase were from Boehringer. 
All other reagents used were of the highest degree 
commercially available. 
2.2. Methods 
2.2.1. Preparation of F1,6Pzase 
F1,6Pzase was purified from rat liver as in [14]. 
This yielded an enzyme which was homogeneous as 
judged from polyacrylamide gel electrophoresis in 
detergent, and with an apparent subunit M, of 
37 000 [18]. The specific activity was 9-14 
units/mg and the ratio of activity at pH 7.5 to that 
at pH 9.2 was 1.6 for the purified enzyme and did 
not change after chromatofocusing. This ratio is 
below 1 for enzyme modified with subtilisin as 
reported in [19]. 
2.2.2. Purification of protein kinase 
The catalytic subunit of CAMP-stimulated pro- 
tein kinase was prepared as in [20], but with the 
modifications in [18]. One unit is defined as the 
amount of enzyme that can transfer 1 pmol phos- 
phate from ATP to mixed histone per min at 30°C. 
2.2.3. Phosphorylation of FI,6Pzase 
Purified rat liver enzyme (430 pug) was phos- 
phorylated with 420 units of catalytic subunit from 
CAMP-dependent protein kinase and 0.5 mM 
[32P]ATP as in [ 181. It was possible to phos- 
phorylate the enzyme to 1 mol/mol enzyme sub- 
unit, but to obtain similarly treated samples of 
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phosphorylated and unphosphorylated enzyme the 
reaction was interrupted earlier. After 1 h at 30°C 
in the presence of 25 mM 2-(N-morpholino)ethane- 
sulfonic acid buffer (pH 6.9), 4 mM magnesium 
acetate, 2pM CAMP, 1 mM DTT, the reaction was 
terminated by chromatography on a Sephadex 
G-50 column equilibrated with 25 mM histidine- 
HCl buffer (pH 7.0), 1 mM DTT, 0.1 mM F1,6Pz, 
30% glycerol. The protein was eluted in the void 
volume. 
2.2.4. Chromatofocusing of F1,6Pzase 
The phosphorylated enzyme was chromato- 
focused on a column (0.6 x 3.5 cm) packed with 
Polybuffer Exchanger, equilibrated with 25 mM 
histidine-HCI buffer (pH 5.75), 1 mM DTT, 0.1 
mM F1,6Pz, 30% glycerol. Three mg protein was 
applied per ml gel. Prior to application the pH of 
the sample was adjusted to 5.75. 
The F1,6Pzase was eluted with Polybuffer 74 
(diluted 10 times) (pH 3.5), 1 mM DTT, 0.1 mM 
F1,6Pz, 30% glycerol. Fractions of 200,ul were col- 
lected in test tubes to which 50 ~1 1 M Tris-HCl 
buffer (pH 7.5) had been added to minimize ex- 
posure of the enzyme to low pH. Some tubes left 
without these additions were used for pH deter- 
mination, using a microelectrode unit (Radio- 
meter, Copenhagen). 
2.2.5. Dephosphorylation of Fl,6Pzase 
Phosphorylated and chromatofocused F1,6Pz- 
ase (0.57 nmol subunit) was treated with 0.13 unit 
of low M, phosphoprotein phosphatase, prepared 
as in [21]. One unit of phosphatase is the amount 
of enzyme which can release 1 nmol [32P]-phos- 
phate from [32P]phosphohistone p r min at 30°C. 
The reaction took place in the presence of 50 mM 
‘Tris-HCl buffer (pH 7.5), 6 mM DTT, 1.25 mM 
MgS04,O. 1 mg/ml bovine serum albumin at 30°C 
in a total volume of 2 ml. The material was used 
for activity measurements. 
2.2.6. Assay of F1,6Pzase 
The analyses were performed essentially as in 
[18]. The amount of sample used in the test was 
chosen to give an activity of 4.5 milliunits, when 
measured at optimal substrate concentration. One 
unit is defined as the amount of enzyme that can 
dephosphorylate 1 pmol Fl,6P2 per min. The 
purified enzyme had a specific activity of 10 
units/mg protein as reported in [18]. 
The reaction mixture consisted of 25 mM 
potassium phosphate buffer (pH 7.5), 25 mM 2- 
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mercaptoethanol, 1 mg/ml bovine serum albumin, 
2.5 mM MgS04, 0.4 mM NADP, 0.7 unit glucose- 
6-phosphate dehydrogenase, 0.35 unit phospho- 
hexose isomerase; final volume 600 ~1. This mix- 
ture was preincubated with the sample (5-40 ~1, 
determined as above) for 3 min at 30°C. Prior to 
the kinetic studies, the enzyme was dialyzed 
against 25 mM histidine-HCl buffer (pH 7.0), 1 
mM DTT, 30% glycerol. 
In analyses where F2,6Pz, AMP or both were 
present, the effecters were preincubated together 
with the enzyme. F2,6Pz was dissolved in 0.5 mM 
Tris-HCI (pH 8.6). To ensure that the noted effect 
was independent of pH, an equal amount of this 
buffer was added to the samples, which were 
assayed without the sugar derivative. 
The reaction was started by the addition of 
Fl,6Pz, giving final concentrations up to 33 PM, 
and the reaction took place at 30°C. 
2.2.7. Other methods 
To check whether the radioactivity found in the 
chromatograms was bound to proteins, aliquots 
containing between 2000 and 10 000 -cpm 
Fig. 
(Cerenkov radiation) were taken, 1 ml bovine 
serum albumin was added, and the protein was 
precipitated with 2 ml ice-cold trichloroacetic acid 
(10070, w/v) with 50 mM phosphoric acid and the 
radioactivity in the pellet, dissolved in 0.5 ml of 0.5 
M NaOH, was measured. All protein determina- 
tions were made as in [22]. 
3. RESULTS AND DISCUSSION 
Chromatofocusing of partially phosphorylated 
F1,6Pzase gave two activity peaks - one with an 
apparent pl of about 4.5, the other of about 5.0 
(fig.1). The yield of activity was 95-100% in the 
chromatofocusing step and the specific activity 
was still 10 units/mg.’ Reports on the specific ac- 
tivity of F1,6Pzase vary between 6 [23] and 45 
units/mg [17]. Since the concentrations of effec- 
tors vary in the assays described by different 
authors, it is difficult to make a direct comparison 
of the values. In this laboratory values of 9-14 
units/mg for a homogeneous preparation are 
typical. Some comments on the influence of dif- 
80 100 
Fraction number 
1. Chromatofocusing of F1,6Pzase, partially phosphorylated in vitro. Enzyme activity at 80 ,uM F1,6P2 (M), 
cpm/ml (M) and pH gradient (M) were measured. 
205 
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ferent effecters on the activity of F1,6Pzase can be 
found in [24]. 
Most of the radioactivity was recovered in the 
peak with lower pL Following this peak, and well 
separated from it, another peak with a smaller 
amount of radioactivity appeared. It was found 
that more than 99.9% of the radioactivity in the 
peak with pI 4.5 was protein-bound. This value 
was less than 0.5% for the latter. The non-protein- 
bound radioactivity represents ATP, which was 
adsorbed to the proteins, and therefore was not 
fully separated from the enzyme under the condi- 
tions used for chromatography on the Sephadex 
G-50 column. 
The F1,6Pzase found at pH 5.0 was completely 
unphosphorylated and displayed a &.s of 15 PM 
for F1,6P2 and the enzyme form with lower p1 was 
completely phosphorylated and showed a KO.S of 
10 PM. This should be compared with the values 
reported earlier, where it has been found that 
phosphorylation in vitro decreased Ko.5 from 22 to 
11 ,uM [18]. After dephosphorylation of the phos- 
phorylated chromatofocused F1,6Pzase the KO.S 
coincided exactly with that of unphosphorylated 
enzyme prior to chromatofocusing. The unphos- 
phorylated enzyme was subjected to the same addi- 
tions except for the phosphoprotein phosphatase. 
It was demonstrated that F,6Pzase, fully phos- 
phorylated in vitro, was less sensitive to inhibition 
by F2,6Pz than the unphosphorylated form of the 
enzyme. As seen in fig.2 the concentration re- 
quired for 50% inhibition, measured at 12.5 PM 
F1,6Pz, was found to be 4 ,uM for the phosphoen- 
zyme and 2pM for the unphosphorylated form. At 
higher substrate concentration (33 ,uM) the cor- 
responding values were found to be 11 and 4 PM, 
respectively. 
The amount of F2,6Pz needed for 50% inhibi- 
tion of the unphosphorylated enzyme reported 
here is in good agreement with values reported for 
unphosphorylated Fl,6P2 from rat liver (3.5 ,uM 
[8], 1.4pM [ll]), swine kidney (2.5 /IM [9], 2 PM 
[12]) and rabbit liver (5 FM [7]). 
The results suggested that the inhibitor acts in a 
competitive fashion for both enzyme forms, and 
the Ki values were estimated to be about 1.5pM for 
the unphosphorylated and 3 ,uM for the phos- 
phorylated enzyme. 
It was reported in [12] that F1,6Pzase in cytosol 
from rats injected with glucagon is activated, prob- 
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Fig. 2. Inhibition of rat liver F1,6Pzase by F2,6Pr. 
Activity of phosphorylated and unphosphorylated 
enzyme was measured at 33 and 12.5 pM Fl,6Pz. The 
amount of inhibitor was varied as indicated. Phos- 
phorylated enzyme measured at 33 PM (O--O) and 
12.5 pM (o---o) and unphosphorylated enzyme at 33 
,sM (M) and 12.5 PM (M) substrate. 
ably due to phosphorylation of the enzyme in 
response to the hormone. At the same time, the 
sensitivity of the enzyme to inactivation by F2,6Pz 
is lowered so that the Ki value of 0.1 FM observed 
for control animals is approximately doubled on 
injection of glucagon. These results could not be 
expected to coincide exactly with ours since we 
work with an in vitro system with purified en- 
zymes, and these authors with liver cytosol, con- 
taining all metabolites of the cell. 
Authors in [l l] reported a Ki of 0.5 PM when 
working with purified unphosphorylated 
F1,6Pzase from rat liver. One possible explanation 
for the discrepancy could be differences in Mg2+ 
concentration. Authors in [25] showed that Mg2+ 
inhibits the binding of F2,6P2 to F1,6Pzase: at 250 
PM Mg2+ only 0.28 mol F2,6P2 had bound per mol 
subunit compared to 0.50 mol/mol at 50,~M and 
0.61 mol/mol in the absence of Mg’+. The concen- 
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trations used were 2 mM plus 0.1 mM EDTA [ 1 l] 
and 2.5 mM (here). These concentrations are well 
within the range of physiological concentration of 
5-10 ,umol/g wet wt reported in [26]. 
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Fig. 3. The influence of F2,6Pz and AMP on the activity 
of F1,6Pzase. Activity of phosphorylated (m) and 
unphosphorylated (M) enzyme without inhibitor. 
(A) Phosphorylated (M) and unphosphorylated 
(H) F1,6Pzase assayed in the presence of 4 /cM 
F2,6Pz. (B) Phosphorylated (O-+) and unphos- 
phorylated (M) enzyme with 25 CM AMP. (C) Phos- 
phorylated (W) and unphosphorylated @‘k-m) 
25 50 75 100 
AMP (uM) 
Fig. 4. The effect of AMP on the activity of F1,6P~ase. 
Activity of phosphorylated (m), dephosphorylated 
(~sc-n) and unphosphorylated (ti) F1,6Pzase 
measured at 33 pM F1,6Pz. The concentration of AMP 
enzyme with both 4 pM F2,6Pz and 25 ,uM AMP. was varied as indicated. 
F2,6Pz at 4pM was also found to lower V,, for 
both enzyme forms to about 70% of the un- 
inhibited value for phosphorylated and 55% 
for unphosphorylated and dephosphorylated 
F1,6P~ase (fig.3A). The concentrations of F1,6P2 
used in these experiments were chosen to avoid the 
substrate inhibition observed at high concentra- 
tions in [8]. 
Addition of 25 PM AMP lowered V,, to 70% 
(phosphorylated) and 40% (unphosphorylated, 
fig.3B, and dephosphorylated forms, fig.4) of un- 
inhibited values. 
AMP plus 4 FM F2,6P2 added simultaneously 
had a very dramatic effect. Vmax was decreased to 
20% for the phosphorylated enzyme form, and on- 
ly 5% activity was found for the unphosphorylated 
one under our conditions (fig.3C). This latter in- 
hibition is more than additive, and indeed, all 
authors working with mammalian unphos- 
phorylated F1,6Pzase have reported that AMP and 
F2,6P2 act synergistically [7-111. Authors in [25] 
have also shown that up to 2OpM AMP has no ef- 
fect on the amount of F2,6P2 bound to F1,6Pzase, 
so it seems to be certain that the two inhibitors in- 
deed bind to different sites in the molecule. 
The most reasonable conclusion from our results 
is that the amount of F2,6P2 bound to F1,6Pzase 
varies with the state of phosphorylation of the en- 
zyme, thus modifying its activity. There has been 
no comparative study of the binding capacity of 
b:-,, 
207 
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Fig. 5. Dephosphorylation of F1,6Pzase. Change in ac- 
tivity (M) of phosphorylated F1,6Pzase and release 
of [32P]phosphate (M) during dephosphorylation. 
The reaction was performed as described in section 2 and 
samples were withdrawn and analysed at the times in- 
dicated. The enzymatic activity was measured at 20 ,uM 
F1,6Pz in the presence of 4pM F2,6Pz and 25 PM AMP. 
The initial activity was 100% and all the radioactivity 
was released after 30 min incubation. 
the two enzyme forms, but it seems probable that 
unphosphorylated enzyme binds both F2,6Pz and 
AMP more tightly than does its phosphorylated 
counterpart. This is analogous to the results 
reported for 6-phosphofructo-1-kinase [27,28] 
where unphosphorylated enzyme is reported to 
show greater affinity for F2,6P2 which, in this 
case, results in a decreased sensitivity to ATP 
inhibition. 
Treatment of hepatocytes with glucagon induces 
phosphorylation of not only F1,6Pzase and 6- 
phosphofructo-1-kinase but also of the bifunc- 
tional enzyme 6-phosphofructo-2-kinase1F2,6Pz- 
ase [2], which leads to inhibited synthesis and in- 
creased degradation of F2,6P2 and a dramatic 
decrease in the concentration of the effector from 
about 16 to about 2 nmol/g [29]. So as a result of 
glucagon administration the amount of unphos- 
phorylated F1,6Pzase, more sensitive to inhibition 
by the effector, and that of unphosphorylated 
6-phospho-1-kinase, more easily activated by the 
effector, are both lowered, as is the concentration 
of the effector itself. The total result will be 
stimulation of gluconeogenesis and inactivation of 
glycolysis, a well known consequence of glucagon 
administration or starvation. 
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